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Ectopic Expression of Activated Stat6 Induces
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a differentiation signal (Ryan et al., 1996; Wang et al.,
1996), while the IRS-1/2 pathway is a growth regulator
(Keegan et al., 1994; Quelle et al., 1995; Lederer et al.,
1996; Ryan et al., 1996; Wang et al., 1996). Stat6 is an
848±amino acid protein and shares homologous do-
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mains with other Stat proteins, including an N-terminalPalo Alto, California 94304
domain, a DNA-binding domain (DBD), SH3 and SH2
domains, and a C-terminal transactivation domain (TAD)
(Quelle et al., 1995; Lu et al., 1997; Moriggl et al., 1997).Summary
Upon phosphorylation of its tyrosine residue, Stat6 ho-
modimerizes, translocates into the nucleus, and bindsStat6 is critical for IL-4-mediated Th2 cell develop-
to specific sequences located in the promoters of IL-4-ment, but its molecular mechanism remains unclear.
responsive genes (Hou et al., 1994; Quelle et al., 1995).Here we constructed Stat6:ER, a Stat6-estrogen re-
Stat6-deficient mice show defective Th2 responses, in-ceptor fusion protein that can be activated by 4-hydroxy-
dicating that Stat6 is critical for Th2 cytokine inductiontamoxifen, independently of IL-4 and endogenous
(Kaplan et al., 1996; Shimoda et al., 1996; Takeda et al.,Stat6. Retrovirus-mediated introduction of Stat6:ER
1996; Ouyang et al., 1998). However, activation of Stat6into developing Th1 cells induced Th2-specific cyto-
signaling occurs rapidly (Abbas et al., 1996), while thekines and suppressed IFNg production in a 4-HT-
development of Th2 cells occurs over a few days. Itdependent manner and in the absence of IL-4. It also
remains unclear whether Stat6 is sufficient to induce ainduced GATA-3 and c-maf expression and downregu-
Th2 cell phenotype.lated IL-12Rb2 chain expression. Its decreased ability
The transcription factors GATA-3 and c-Maf are selec-to induce the Th2 phenotype with progressing Th1 cell
tively expressed in Th2 but not Th1 cells (Ho et al., 1996;commitment correlated with a decreased induction of
Zhang et al., 1997; Zheng and Flavell, 1997). GATA-3GATA-3 and c-maf. This study indicates that Stat6
strongly transactivates the IL-5 promoter and weaklyfunctions upstream of GATA-3 and c-Maf to induce
activates the IL-4 promoter (Zhang et al., 1997; Lee etTh2 development.
al., 1998; Ranganath et al., 1998; Zhang et al., 1998).
Furthermore, its ectopic expression in developing Th1Introduction
cells leads to upregulation of IL-4 and IL-5 and downreg-
ulation of IFNg partly by downregulating the IL-12 recep-CD41 T helper cells (Th) develop into at least two distinct
tor b2 (IL-12Rb2) chain (Zheng and Flavell, 1997; Ouyangsubsets with different functional capabilities and cyto-
et al., 1998; Ferber et al., 1999). c-Maf appears to act askine profiles (Mosmann et al., 1986; Mosmann and Coff-
a synergistic factor in Th2-specific cytokine production
man, 1989). Th1 cells produce interferon (IFN)-g and
and downregulates IFNg production in Th cells cultured
lymphotoxin, confer cell-mediated immunity against in-
under nonskewing conditions (Ho et al., 1996, 1998).
tracellular pathogens, and mediate delayed-type hyper- Progressive polarization of CD41 T cells under Th1-
sensitivity (DTH) and organ-specific autoimmune dis- or Th2-inducing conditions ultimately leads to the com-
eases (Mosmann and Coffman, 1989; Abbas et al., 1996; mitment of mutually exclusive Th phenotypes (Murphy
O'Garra, 1998). In contrast, Th2 cells produce IL-4, IL-5, et al., 1996; Nakamura et al., 1997), as observed after
and IL-13, control the eradication of extracellular hel- chronic antigenic stimulation such as in parasitic dis-
minthic pathogens, and are implicated in atopic and eases or allergic manifestations (Romagnani, 1994). The
allergic manifestations (Romagnani, 1994). The develop- molecular basis for the commitment of Th phenotypes
ment of these discrete subsets of Th cells is determined can be explained, in part, by specific loss of cytokine
by a number of factors, including cytokines, dose and receptors such as the IL-12Rb2 chain, which is lost in
form of antigens, antigen-presenting cells, costimula- Th2 cells but maintained in Th1 cells (Rogge et al., 1997;
tors, and the genetic background of the responding host Szabo et al., 1997). Furthermore, IL-4 upregulates the
(Abbas et al., 1996; Constant and Bottomly, 1997; IL-4Ra chain (Kotanides and Reich, 1996) and downreg-
O'Garra, 1998). Cytokines, such as IL-12 and IL-4, play ulates the IL-12Rb2 chain (Szabo et al., 1997), whereas
a dominant role in driving the development of Th1 and IFNg upregulates the IL-12Rb2 chain (Szabo et al., 1997).
Th2 cells, respectively (Swain et al., 1990; Hsieh et al., Moreover, IL-4R-mediated activation of Stat6 and
1993; Nelms et al., 1999). IRS-2 was shown to be blocked in Th1 cells (Huang et al.,
Ligand binding to the IL-4 receptor (IL-4R) activates 1997; Kubo et al., 1997). Undoubtedly, additional molec-
Jak1 and Jak3, leading to recruitment and phosphoryla- ular events, including the induction of Th-type specific
tion of Stat6, IRS-1/2, Shc, and SHP-1 (Ryan et al., 1996; transcription factors such as GATA-3 and c-Maf and the
Wang et al., 1996; Zamorano and Keegan, 1998). Distinct chromatin remodeling of cytokine genes, may also be
regions of the IL-4Ra chain are involved in the activation involved in the commitment of cells toward a Th1 or Th2
of these pathways, where the Stat6 pathway transfers phenotype (Ho et al., 1996; Zheng and Flavell, 1997;
Agarwal and Rao, 1998a; Murphy et al., 1999).
We have previously shown that 4-hydroxytamoxifen* To whom correspondence should be addressed (e-mail: arai@
dnax.org). (4-HT)-mediated activation of a Stat6-estrogen receptor
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Figure 1. 4-HT-Mediated Activation of Stat6:ER in Developing Th1 Cells Induces Th2 Cytokine Expression and Suppresses IFNg Expression
(A) Retroviral vectors containing Stat6:ER, ER, and EGFP. RV-Stat6:ER-IRES-EGFP contains a Stat6:ER cDNA, IRES, and EGFP cDNA between
the long terminal repeats of the murine stem cell virus (MSCV). RV-ER-IRES-EGFP was used as a control.
(B) Retrovirus infection and analyses. Naive CD41 T cells from DO11.10 TCRab transgenic mice were infected with retroviruses on days 1
and 2 after activation and cultured under the Th1 condition in the presence (0.3 mM) or absence of 4-HT. GFP-positive and -negative populations
were isolated by FCM on day 7 and analyzed for cytokine profiles on days 7 and 14.
(C) Cytokine ELISA of developing Th1 cells infected with RV-Stat6:ER-IRES-EGFP. GFP-positive and -negative cells were harvested on day
7 from cultures in the presence or absence of 4-HT and restimulated at 5 3 105 cells/ml with antigen OVA and APCs for 48 hr. Uninfected
Th1 and Th2 cells were analyzed simultaneously. Similar results were obtained on day 14 or by stimulation with PMA and ionomycin. The
lower limits of detection were 2.5 ng/ml for IFNg, 0.4 ng/ml for IL-4, 0.4 ng/ml for IL-5, and 1 ng/ml for IL-10. The asterisks indicate levels
lower than the detection limits.
(D) Expression of IL-4 and IFNg in T cells infected with ER- (control) or Stat6:ER-containing retroviruses. The sorted GFP-positive cells were
cultured as in (C), restimulated with PMA and ionomycin for 6 hr, and analyzed for cytokine expression by FCM. Similar results were obtained
in four independent experiments.
(ER) fusion protein (Stat6:ER), supposedly by inducing we introduced the Stat6:ER fusion protein into devel-
oping Th1 cells by a retroviral vector. Activation ofits dimerization and nuclear translocation, mimicked
the functional consequences of IL-4-mediated Stat6 Stat6:ER by 4-HT was sufficient for the induction of Th2-
specific cytokines in developing Th1 cells. Moreover, thetyrosine phosphorylation (Kamogawa et al., 1998). The
expression of CD23 was upregulated by activated ability of Stat6:ER to induce a Th2 phenotype correlated
with the induction of GATA-3 and c-maf mRNA ex-Stat6:ER, independently of IL-4, in a B lymphoma cell
line, M12 (Kamogawa et al., 1998). In the present study, pression.
IL-4-Independent Th2 Development by Stat6:ER
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Figure 2. Structures, Expression, and DNA-
Binding Activity of Stat6:ER and Its Mutants
in M12 Cells
(A) Structures of the Stat6:ER fusion protein
and its mutants. Stat6:ER contains a full-
length mouse Stat6 and an HBD of ER. DDBD
contains a deletion of DBD of Stat6. Mut DBD
contains a substitution of amino acids at po-
sitions from 411 to 413 within DBD. DTAD
contains a deletion of TAD.
(B) Retrovirus-mediated expression of
Stat6:ER or its mutants in M12 cells. M12
cells infected with retroviruses containing
Stat6:ER or its mutants were analyzed. Cell
lysates were immunoprecipitated with anti-
Stat6 antibody, and immunoblotted with anti-
Stat6 (lanes 1±5) or anti-ERa antibody (lanes
6±10). Parental M12 cells were also examined
(lanes 1 and 6).
(C) EMSA using nuclear extracts from the
same cell lines as in (B). The cell lines were
cultured in the presence of 1 mM 4-HT for 12 hr.
The binding to a probe containing a Stat6-
consensus sequence from the mouse IL-4 pro-
moter was examined. The nuclear extracts
were preincubated with antibodies (lanes
7±9) or a 50-fold molar excess of unlabeled
oligonucleotides (lanes 10 and 11).
Results uninfected Th1 cells (Figure 1C). In contrast, GFP-nega-
tive cells, as well as Stat6:ER Th1 cells cultured in the
absence of 4-HT, were similar to the control uninfectedActivation of Retrovirally Infected Stat6:ER Induces
the Expression of Th2 Cytokines and Suppresses Th1 cells (Figure 1C). Although IL-5 induction by
Stat6:ER was not prominent on day 7 (Figure 1C), itthe Expression of IFNg in Developing Th1 Cells
To directly analyze the role of Stat6 in Th2 development, became more prominent on day 14 (data not shown). The
induction of IL-4 and downregulation of IFNg in 4-HT-we constructed Stat6:ER, a conditionally active form of
Stat6 that encodes a fusion protein of full-length Stat6 activated Stat6:ER Th1 cells was further confirmed by
intracellular cytokine analysis (Figure 1D). After stimulationand the hormone-binding domain (HBD) of the estrogen
receptor a that is activated specifically by an estrogen with PMA and ionomycin on day 14, 45% of Stat6:ER Th1
cells expressed IL-4, while 40% produced markedly re-analog, 4-HT (Kamogawa et al., 1998). Purified CD41
Mel-14high naive T cells from DO11.10 TCRab transgenic duced levels of IFNg, only in the presence of 4-HT (Figure
1D), demonstrating the 4-HT-dependent effects ofmice were infected by a retroviral vector RV-Stat6:ER-
IRES-EGFP (RV-Stat6:ER) that contains a bicistronic el- Stat6:ER. In contrast, the sorted GFP-positive cells from
RV-ER-infected cells (ER Th1 cells) showed cytokineement coexpressing Stat6:ER and EGFP (Figure 1A).
RV-ER-IRES-EGFP (RV-ER) was used as a control vector patterns comparable to control Th1 cells, irrespective of
the addition of 4-HT (Figure 1D). Furthermore, cell popula-(Figure 1A). Cells were activated with antigen and anti-
gen-presenting cells (APCs) and cultured under Th1- tions expressing IL-5, IL-6, and IL-10 were increased in
the Stat6:ER Th1 cells in a 4-HT-dependent manner (datainducing conditions (IL-12 plus anti-IL-4) in the presence
or absence of 4-HT (Figure 1B). On day 7, the GFP- not shown). The data indicate that Stat6 activation is suffi-
cient for the induction of Th2 cytokines and suppressionpositive and -negative cells were isolated by flow cytom-
etry (FCM), expanded, and on day 14 analyzed for of IFNg production in developing Th1 cells.
cytokine production upon stimulation. GFP-positive cells
purified from RV-Stat6:ER-infected developing Th1 cells DNA Binding and Transactivation Domains of Stat6
Are Required for 4-HT-Dependent Transactivation(Stat6:ER Th1 cells) cultured in the presence of 4-HT
showed a markedly reduced level of IFNg and elevated Stat6 contains several functional domains including
DNA-binding (DBD), SH3, SH2, and transactivationlevels of IL-4, IL-5, and IL-10 as compared with control
Immunity
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Figure 3. Both the DBD and TAD of Stat6 Are Required for the 4-HT-Mediated Induction of Th2 Cytokine Expression in Developing Th1 Cells
Naive T cells from DO11.10 TCRab-transgenic mice were activated as in Figure 1 and infected with retroviruses containing wild-type and
mutant Stat6:ERs. GFP-positive cells were restimulated with OVA and APCs on day 14 and analyzed as in Figure 1C. Similar results were
obtained by stimulation with PMA and ionomycin.
(TAD) domains (Mikita et al., 1996; Moriggl et al., 1997) results were obtained by FCM analysis of intracellular
cytokine production (data not shown). These data sug-(Figure 2A). Three amino acids VVI at positions 411±413
within the DBD are critical for binding to the consensus gest that both the DBD and TAD of Stat6 are crucial for
Stat6:ER-mediated Th2 development.sequence (Mikita et al., 1996), and the C-terminal TAD
is required for its transactivation function (Moriggl et al.,
1997). Activation of Stat6:ER Induces Th2-Specific Cytokine
Expression and Suppresses IFNg in the CompleteTo determine whether the functional domains of Stat6
are required for the induction of Th2 cell differentiation Absence of IL-4
To address whether the Th2 phenotype induction is aand to ensure that Stat6:ER was functioning in a Stat6-
specific manner, we generated retroviruses containing direct effect of Stat6:ER or mediated by a paracrine loop
of IL-4, we performed parallel experiments using naiveSTAT6:ERs with different mutations, including (1) a dele-
tion of the DBD (DDBD), (2) a substitution of three critical CD41 T cells (IL-42/2 DO11.10) and APCs (IL-42/2) from
IL-4-deficient mice (Kuhn et al., 1991). Stat6:ER Th1 cellsamino acids within the DBD (mut DBD), and (3) a deletion
of the TAD (DTAD) (Figure 2A). Infected M12 cells from IL-42/2 DO11.10 mice showed 4-HT-dependent in-
creases in IL-5 and IL-10 production and a marked de-showed expression of the four Stat6:ERs with predicted
sizes: wild-type Stat6:ER and mut DBD, 129 kDa; DDBD, crease in IFNg production, in contrast to the control Th1
cells on day 7 (Figure 4A). The same and more accentu-116 kDa; DTAD, 110 kDa; and endogenous Stat6, 94
kDa (Figure 2B). We have previously shown by EMSA ated pattern of cytokine production was observed at
day 14, while RV-mut DBD-infected developing Th1 cellsthat the DNA binding of Stat6:ER is induced by 4-HT
but not IL-4, while the binding of endogenous Stat6 is (mut DBD Th1 cells) and control Th1 cells showed a Th1
pattern (Figure 4B).induced only by IL-4 (Kamogawa et al., 1998). Among
the above four constructs, only the wild-type Stat6:ER Stat6:ER Th1 cells from DO11.10 mice showed a
marked increase in IL-4, IL-5, IL-10, IL-13, and IL-6and the DTAD mutant showed binding activity to the
Stat6-consensus element of the mouse IL-4 promoter mRNAs and a decrease in IFNg and IL-2 mRNAs in a
4-HT-dependent manner, as measured by ribonuclease(Figure 2C, lanes 2 and 3). The binding specificity was
confirmed by antibody supershift (lanes 7±9) and com- (RNase) protection (Figure 4C, lanes 3 and 4). A similar
change, except for IL-4 mRNA, was observed in IL-42/2petition with unlabeled oligonucleotides (lanes 10 and
11). Furthermore, upregulation of CD23 was induced DO11.10 cells (Figure 4C, lanes 5 and 6). Thus, the induc-
tion of Th2-specific cytokines and the downregulationonly by the wild-type Stat6:ER (Kamogawa et al., 1998)
but not the three mutants, while all four M12 cell lines of the Th1 phenotype by activated Stat6:ER was inde-
pendent of IL-4.upregulated CD23 in response to IL-4 (data not shown).
These data indicate the requirement for the same func-
tional domains as endogenous Stat6 for DNA binding Activation of Stat6:ER in Developing Th1 Cells
Inhibits IL-12Rb2 Expressionand upregulation of CD23 in M12 cells (Mikita et al.,
1996). To test whether Stat6:ER inhibited IFNg production by
downregulating the IL-12Rb2 chain, we analyzed IL-12To examine whether these functional domains of Stat6
were required for the Th2 cytokine production in devel- receptor mRNA expression by RNase protection. Unin-
fected Th1 cells showed a marked increase in the ex-oping Th1 cells, naive CD41 T cells infected with retrovi-
ral vectors containing wild-type or mutant forms of pression of IL-12Rb2 mRNA, while IL-12Rb2 mRNA wasnot
detected in developing Th2 cells (Figure 5A, left panel).Stat6:ER were analyzed as described in Figure 1. Only
the wild-type Stat6:ER Th1 cells showed a 4-HT-depen- Stat6:ER Th1 cells preferentially showed decreased ex-
pression of IL-12Rb2 mRNA in a 4-HT-dependent man-dent decrease in IFNg production and increase in IL-4,
IL-5, and IL-10 production. In contrast, all three mutant ner. In contrast, mut DBD Th1 cells were comparable to
uninfected Th1 cells. The expression of IL-12Rb2 mRNAStat6:ER Th1 cells showed a Th1 cytokine profile, irre-
spective of the addition of 4-HT (Figure 3). Compatible was also suppressed by Stat6:ER in IL-42/2 DO11.10
IL-4-Independent Th2 Development by Stat6:ER
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Figure 4. Stat6:ER Induces Th2 Cytokine Ex-
pression and Suppresses IFNg in the Ab-
sence of IL-4
IL-42/2 DO11.10 Stat6:ER Th1 cells or mut
DBD Th1 cells were analyzed on day 7 (A)
and day 14 (B), as in Figures 1C and 3. Control
uninfected IL-42/2 DO11.10 T cells were cul-
tured in the Th1 or Th2 culture conditions.
Similar results were obtained by stimulation
with PMA and ionomycin. (C) RNase protec-
tion assay of cytokine mRNAs. Stat6:ER Th1
cells from DO11.10 (lanes 3 and 4) and IL-42/2
DO11.10 mice (lanes 5 and 6) were stimulated
with PMA and ionomycin for 6 hr on day 14.
Uninfected Th1 and Th2 cells were analyzed
simultaneously (lanes 1, 2, 7, and 8).
Th1 cells, although to a lesser extent (Figure 5A, right in a 4-HT-dependent manner (Figure 5B, lanes 3 and 4),
while no significant expression was observed in mutpanel), suggesting that Stat6:ER downregulates IL-
12Rb2 mRNA expression via IL-4-dependent and inde- DBD Th1 cells cultured with 4-HT (Figure 5B, lanes 5
and 6). Parallel experiments with IL-42/2 DO11.10 T cellspendent mechanisms.
showed that GATA-3 and c-maf mRNA expression was
also induced in the absence of IL-4 (Figure 5B, lanesActivation of Stat6:ER in Developing Th1 Cells Induces
7 and 8), indicating that these genes are downstreamthe Expression of the Th2-Specific Transcription
targets of Stat6.Factors GATA-3 and c-maf
Since GATA-3 (Zheng and Flavell, 1997; Ouyang et al.,
1998; Ranganath et al., 1998; Zhang et al., 1998; Ferber Induction of Th2-Specific Cytokines and Inhibition
of IFNg by Activated Stat6:ER Is Limited toet al., 1999) and c-Maf (Ho et al., 1996, 1998) play impor-
tant roles in Th2 cell development, we examined the Early Stages of Th1 Cell Development
Commitment of Th1 and Th2 cells require multipleeffect of Stat6:ER on GATA-3 and c-maf mRNA expres-
sion by RNase protection. Stat6:ER Th1 cells expressed rounds of stimulation with antigen and APCs in the pres-
ence of IL-12 and IL-4, respectively (Murphy et al., 1996).significant amounts of both GATA-3 and c-maf mRNAs
Immunity
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which activation of Stat6:ER showed no differences in
IFNg and no production of IL-4 from uninfected or
Stat6:ER HDK1 cells cultured without 4-HT (data not
shown). These results suggest that even the forced acti-
vation of Stat6:ER cannot convert the phenotype of
long-term polarized Th1 cells.
With activation by 4-HT from day 1, the induction of
GATA-3 and c-maf mRNAs was observed in Stat6:ER
Th1 cells (Figure 6B, lane 3) but not in ER Th1 cells
(Figure 6B, lane 7). The induction levels of the mRNAs
decreased gradually when the start of the addition of
4-HT was delayed (Figure 6B, lanes 4±6). However, if 4-HT
was added from as late as day 21, little or no GATA-3
or c-maf mRNA expression was observed (Figure 6B,
lane 6), which correlated with the levels of Th2 pheno-
type induction (Figure 6A). Moreover, Stat6:ER activa-
tion resulted in no induction of GATA-3 and c-maf
mRNAs in a committed Th1 clone HDK1 (Figure 6B, lanes
11 and 12), compatible with the inability of Stat6:ER to
induce the Th2 phenotype.
Growth Promotion of Stat6:ER-Activated Developing
Th1 Cells Is Lost upon Commitment
Although Stat6 and IRS-2 signals are activated by dis-
tinct regions of the IL-4 receptor (Ryan et al., 1996),
Stat6-deficient lymphocytes have been shown to be de-
fective in their proliferative responses to IL-4 (Kaplan et
al., 1996; Shimoda et al., 1996; Takeda et al., 1996). To
investigate whether activated Stat6 can enhance the
proliferation of developing Th1 cells, we examined theFigure 5. Stat6:ER Induces GATA-3 and c-maf mRNA, While Sup-
pressing the Expression of IL-12Rb2 mRNA in Developing Th1 Cells growth of Stat6:ER Th1 cells treated with different con-
(A) RNase protection assay of IL-12Rb subunit mRNAs. Stat6:ER centrations of 4-HT by [3H]thymidine incorporation (Fig-
and mut DBD Th1 cells from DO11.10 (lanes 3±6) and IL-42/2 ure 7A). The proliferation of Stat6:ER Th1 cells was en-
DO11.10 (lanes 7±8) mice were cultured as in Figure 3. One micro- hanced in a dose-dependent manner on days 10 and
gram of total RNA was analyzed for IL-12Rb1 and 2 subunits and
31 after polarization (Figure 7A), in contrast with that ofL32 (control housekeeping gene). Uninfected Th1 and Th2 cells were
the ER Th1 or uninfected Th1 cells (the effective concen-included as in Figure 3 (lanes 1, 2, 9, and 10).
tration of 4-HT was between 0.08 and 2 mM, and the(B) RNase protection assay of GATA-3 and c-maf mRNAs. One
microgram of total RNA as in (A) was analyzed for GATA-3 and toxic concentration was greater than 5 mM). A marked
c-maf as well as L32 and GAPDH. enhancement of proliferation was also observed in the
RV-Stat6:ER-infected Th2 clone D10 (Figure 7B, upper
right) but not in the RV-Stat6:ER-infected Th1 clone
Such polarized Th1 cells lose their responsiveness to HDK1 (Figure 7B, upper left). The growth enhancement
IL-4 via mechanisms such as selective blocking of Stat6 was Stat6-dependent, since none of the clones express-
and IRS-2 pathways (Huang and Paul, 1998). To address ing mutant Stat6:ERs induced a growth enhancement
whether the block in Stat6 activation is the major mecha- in response to 4-HT (Figure 7B, upper right), while all of
nism for Th1 commitment, Stat6:ER was activated by the clones responded equally to IL-2 (Figure 7B, lower
4-HT at various time points during Th1 cell development panels). These data indicate that Stat6 induced growth
(Figure 6A). After 2 weeks of treatment with 4-HT, intra- promotion in a Th2 clone and developing Th1 cells, but
cellular cytokine profiles were analyzed. The control that this effect is lost in a committed Th1 clone.
Stat6:ER Th1 cells, in the absence of 4-HT produced no
IL-4, while 98% of them expressed IFNg (Figure 6A).
Early activation of Stat6:ER by addition of 4-HT on days Discussion
1±14 (Figure 6A) resulted in a marked increase in IL-4-
producing cells (from 0% to 43%) and a significant de- Gene targeting studies have revealed that Stat6 is criti-
cal for Th2 cell development (Kaplan et al., 1996; Shi-crease in IFNg-producing cells (from 98% to 71%). A 1
week delay in the addition of 4-HT resulted in a lower moda et al., 1996; Takeda et al., 1996) as well as the
induction of GATA-3 (Ouyang et al., 1998). However, itlevel of induction of IL-4-producing cells (20%) and a
decreased level of suppression of IFNg-producing cells remains unclear how Stat6 activates the cascade of
events leading to Th2 cell development. In this study,(93%). Moreover, a 2 or 3 week delay in the addition of
4-HT resulted in substantially lower percentages of IL-4- using 4-HT-mediated activation of Stat6:ER, we showed
that Stat6 activation is sufficient to induce the produc-producing cells (4% and 2%, respectively) and a minimal
decrease in IFN-producing cells (93% and 97%, respec- tion of Th2 cytokines and the downregulation of IFNg in
developing Th1 cells independently of other IL-4 signals.tively). Similar but more profound results were obtained
in a committed Th1 clone HDK1 (Figure 6A, right) in Furthermore, activated Stat6 led to the downregulation
IL-4-Independent Th2 Development by Stat6:ER
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Figure 6. The Induction of Th2 Phenotypes by Stat6:ER Is Limited to Early Stages of Th1 Cell Development
(A) Naive DO11.10 T cells were activated and infected with RV-Stat6:ER, as in Figure 1. 4-HT (0.3 mM) was added for 2 weeks starting from
days 1, 7, 14, or 21, and the cells were analyzed for cytokine expression as in Figure 1D. Stat6:ER Th1 cells cultured without 4-HT were also
shown (left panels). ER Th1 cells showed the same phenotype as the Th1 control, even with the addition of 4-HT from days 1 to 14 (data not
shown). Committed Th1 clone HDK1 infected with RV-Stat6:ER and cultured with 0.3 mM of 4-HT for 2 weeks was analyzed in the same way
(right panels).
(B) RNase protection assay of GATA-3 and c-maf mRNAs. One microgram of total RNA in the same samples as (A) was analyzed for GATA-3
and c-maf, as in Figure 5B. Control uninfected Th1 and Th2 cells cultured for 2 weeks (lanes 1 and 2) as well as RV-Stat6:ER-infected HDK1
cells (lanes 11 and 12) were also examined.
of the IL-12Rb2 chain as well as the induction of GATA-3 phenotype in developing Th1 cells (Figure 3), confirming
that the biological functions of Stat6:ER describedand c-maf mRNAs. The ability of Stat6 to induce the
Th2 phenotype was restricted to an early stage of Th1 herein are derived from Stat6 but not the HBD of ER
(Pritchard et al., 1995).cell development, while no Th2 phenotype was induced
by Stat6 activation in committed Th1 cells and a Th1 Introduction and activation of Stat6:ER in developing
Th1 cells allowed us to dissect the sequence of eventsclone. These results clearly demonstrate that Stat6 func-
tions upstream of GATA-3 and c-Maf as the initiator of ensuing from IL-4R activation. The advantage of this
system is that Stat6:ER can be introduced into naivethe events leading to Th2 development.
In this study, we used a fusion protein of Stat6 to the CD41 T cells at one time point and its activation can be
delayed until the addition of 4-HT. Using this system,HBD of ER, which neither binds estradiol nor possesses
inherent ligand-dependent transactivation activity but we showed that the activation of Stat6:ER at an early
stage during Th1 development led to the induction ofretains responsiveness to 4-HT (Littlewood et al., 1995).
We previously showed that activated Stat6:ER upregu- IL-4 and IL-5 and downregulation of IFNg, while its acti-
vation at later stages did not (Figure 6A).lated CD23 in M12 cells in a manner similar to endoge-
nous Stat6 activated by IL-4 (Kamogawa et al., 1998), The molecular basis for commitment to a Th1 or Th2
phenotype can likely be explained by multiple mecha-and the binding specificity of Stat6:ER to the Stat6-
consensus sequence was confirmed by EMSA (Figure nisms, including (1) differential cytokine signaling, in-
cluding regulated cytokine receptor expression; (2) dif-2C) (Kamogawa et al., 1998). We now demonstrate that
wild-type Stat6:ER but not its mutants induced a Th2 ferential expression of Th-specific transcription factors;
Immunity
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Figure 7. Cell Proliferation Is Specifically Ac-
tivated by Stat6:ER in Developing Th1 Cells
and a Committed Th2 Clone but Not a Com-
mitted Th1 Clone
(A) Proliferation assays were performed with
Stat6:ER Th1, ER Th1, and uninfected Th1
cells on day 10 and 31 after the initial stimu-
lation. Cells were cultured in Th1 culture
conditions in the presence of serially diluted
concentrations of 4-HT for 48 hr, and [3H]thy-
midine was added for the last 6 hr.
(B) Proliferation assays were also performed
with HDK1 cells (left) and D10 cells (right),
which were infected by retroviruses con-
taining Stat6:ER and its mutants. These cells
were incubated with various concentrations
of 4-HT in the presence of 1 ng/ml of IL-2
(upper panels) or various concentrations of
IL-2 (lower panels) for 48 hr, and [3H]thymi-
dine was added for the last 6 hr.
and (3) differential chromatin remodeling of Th1- and Stat6 activation may not be the only reason that a com-
mitted Th1 phenotype is irreversible; rather, Th2-specificTh2-specific genes. With respect to differential cytokine
signaling, commitment to the Th2 phenotype led to a factors other than Stat6 may be lacking in committed
Th1 cells.rapid loss of IL-12 signaling (Szabo et al., 1997). This
can be achieved by a balance between IL-4-mediated Commitment to the Th2 lineage is also dictated by
the differential expression of GATA-3 and c-Maf, bothdownregulation and IFNg-mediated upregulation of the
IL-12Rb2 chain (Szabo et al., 1995, 1997; Rogge et al., of which are important for the regulation of Th1- or Th2-
specific cytokine genes (Ho et al., 1996; Zhang et al.,1997). Thus, it is possible that activation of Stat6:ER
may lead to downregulation of IFNg production partly 1997, 1998; Zheng and Flavell, 1997; Lee et al., 1998;
Ouyang et al., 1998; Ranganath et al., 1998; Ferber et al.,by inhibiting IL-12Rb2 chain expression in developing
Th1 cells. In contrast, the irreversible phenotype of com- 1999) (reviewed in O'Garra, 1998). Ectopically expressed
GATA-3 in developing Th1 cells induced Th2-specificmitted Th1 cells has been explained by a block of Stat6
activation. Tyrosine phosphorylation of JAK3 and Stat6 cytokines and suppressed IFNg production (Zheng and
Flavell, 1997; Ouyang et al., 1998; Ferber et al., 1999).was selectively blocked in Th1 cells, despite the expres-
sion levels of the IL-4R and Stat6 in Th1 cells being However, the induction of Th2-specific cytokines by ec-
topically expressed GATA-3 is limited to an early stagesimilar to those in Th2 cells (Kubo et al., 1997; Huang and
Paul, 1998). In addition, Stat6 may bind to a repressor of Th1 development but is not observed in polarized
Th1 cells or clones (Ouyang et al., 1998). Our studyelement in the 39 untranslated region of the IL-4 gene
and release its suppressive effects in Th2 but not Th1 revealed that the ability of Stat6:ER to induce Th2-spe-
cific cytokines progressively decreased during differen-cells (Kubo et al., 1997). However, since we could not
induce Th2-specific cytokines in committed Th1 cells tiation and correlated well with the levels of GATA-3 and
c-maf mRNA induction (Figure 6B). We confirmed thatby activation of Stat6:ER, it is possible that blocking
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Stat6:ER was functional in committed Th1 cells because this, activated Stat6:ER enhanced the proliferation of
(1) levels of GFP expression reflecting the bicistronic developing Th1 cells, examined on day 10 and 35 follow-
transcript and thus Stat6:ER expression were not differ- ing the initial activation, but not of the committed Th1
ent among Stat6:ER Th1 cells activated at various time clone (Figure 7), suggesting that Stat6-mediated growth
points (Figure 6A), (2) 4-HT-dependent binding to a enhancement may require other factors existing in a Th2
Stat6-consensus sequence probe was still observed by clone and developing Th1 cells but not in a Th1 clone.
EMSA in nuclear extracts from Stat6:ER Th1 cells ob- In conclusion, our results revealed that activated
tained on day 28 after polarization but not in extracts Stat6:ER, in the absence of IL-4, transfers signals suffi-
from mutant Stat6:ER Th1 cells (data not shown), and cient for the induction of Th2 cytokines and suppression
(3) 4-HT-dependent growth enhancement was induced of IFNg in developing but not committed Th1 cells. These
by Stat6:ER on day 10 and 31 (Figure 7). The reason for activities strictly correlated with the induction of GATA-3
the decreased induction of GATA-3 by Stat6:ER remains and c-maf expression, indicating that Stat6 functions
unclear, although the autostimulatory induction of en- upstream of these transcription factors.
dogenous GATA-3 by retrovirally expressed GATA-3
was also lost in committed Th1 cells and a Th1 clone
Experimental Procedures
(H. J. L., unpublished data). It is possible that the compo-
nents required for GATA-3 gene activation may be lost Mice, Cytokines, Antibodies, and Cell Lines
during Th1 development or that chromatin remodeling DO11.10 TCRab transgenic mice (Murphy et al., 1990) and DO11.10
TCRab transgenic crossed with IL-42/2 mice (Kuhn et al., 1991) wererendered the GATA-3 gene inaccessible to transcription
maintained as previously described (Robinson et al., 1997).factors. However, we recently observed that high levels
Purified recombinant mouse IL-2 and IL-4 (DNAX), IL-12 (Phar-of ectopic expression of GATA-3 in committed Th1 cells
Mingen), and rat anti-mouse IL-4 and anti-IL-12 antibodies (kind
and a Th1 clone could induce substantial levels of IL-4 gifts of Drs. W. E. Paul and G. Trinchieri, respectively) were used
and IL-5 production (H. J. L., unpublished data). Taken for cell culture. Polyclonal rabbit anti-mouse Stat6 and anti-mouse
together, our studies indicate that GATA-3 and c-Maf estrogen receptor-a antibodies (Santa Cruz Biotechnology) were
used for immunoprecipitation, immunoblotting, and EMSA. For in-are downstream of Stat6 in the sequence of events lead-
tracellular staining, phycoerythrin (PE)-labeled anti-mouse IL-4 anti-ing to Th2 cell development and that this pathway is
body (PharMingen) and anti-mouse IFNg antibody (DNAX) wereblocked in committed Th1 cells.
used.It has recently been shown that the development of HDK1, D10, and M12 cells were cultured as previously described
naive Th cells into Th1 or Th2 cells is associated with (Kaye et al., 1983; Cherwinski et al., 1987; Kamogawa et al., 1998).
differential chromatin remodeling of IFNg as well as IL-4 A retrovirus packaging cell line, Phoenix-Eco (Dr. G. Nolan, Stanford)
was cultured in DMEM containing 10% FCS in the presence ofand IL-13 genes (Agarwal and Rao, 1998a; Takemoto et
diphtheria toxin (1 mg/ml) and hygromycin B (375 mg/ml) and usedal., 1998), which may be accompanied by DNA demeth-
after three days of culture without the drugs.ylation and histone acetylation (Agarwal and Rao, 1998a;
Bird et al., 1998; Fitzpatrick et al., 1998) and changes
Preparation of Naive CD41 T Cellsin DNase hypersensitivity as in globin gene regulation
Splenic naive T cells were prepared as previously described (Ferberand erythroid differentiation by GATA-1 (Stamatoyanno-
et al., 1999). Briefly, CD41 T cell±rich populations were collectedpoulos et al., 1995). Although the locus control regions
from splenic cells by immunomagnetic negative selection using anti-
and their binding proteins have not been identified, CD8a, anti-Mac-1, and anti-B220 antibodies using BioMAG Separa-
GATA-3 and Stat6 might be strong candidates for long- tors (PerSeptive Biosystems). Naive CD41 T cells were purified by
range chromatin remodeling of the Th2 cytokine gene sorting CD41 Mel-14high populations on a FACStarplus (Becton Dick-
inson) with a purity of above 99%. They were stimulated with antigencluster (Agarwal and Rao, 1998b). During Th1 cell devel-
(0.6 mM OVA323±339) and 3000 rad irradiated BALB/c mouse splenicopment, chromatin structures of Th2-specific cytokine
cells at a density of naive T cells and splenic APCs of 1.25 3 105genes might become more inaccessible to the transcrip-
and 2.5 3 106 cells/ml, respectively, in T cell medium containing 10tion factors or resistant to chromatin remodeling, re-
ng/ml IL-2 (Murphy et al., 1996). For Th1 cultures, 5 ng/ml of IL-12
flecting an irreversible Th1 phenotype (Agarwal and Rao, and 10 mg/ml of anti-IL-4 antibody were added, and, for Th2 cultures,
1998a). 10 ng/ml of IL-4 and 10 mg/ml of anti-IL-12 antibody were added
The development of Th1 and Th2 cells has recently (Murphy et al., 1996).
been shown to require cell cycle progression (Bird et
al., 1998). It has been suggested that during IL-4 signal- Construction of Retroviral Constructs
ing the Stat6 pathway mediates differentiation, while the Enhanced green fluorescent protein (EGFP) encoding vector plas-
mid pMXI-EGFP was provided by Dr. A. Mui (DNAX). pMXI-EGFPIRS-1/2 and Shc pathways stimulate cell proliferation
was prepared by insertion to pMX (Dr. T. Kitamura, DNAX) (Onishi(Keegan et al., 1994; Quelle et al., 1995; Lederer et al.,
et al., 1996) with a BamHI±NotI fragment from the LZRSpBMN-1996; Ryan et al., 1996; Wang et al., 1996; Zamorano
linker-IRES-EGFP (Dr. H. Spits, Netherlands Cancer Center), which
and Keegan, 1998). However, both T and B lymphocytes contains multi-cloning sites and an internal ribosome entry site
from Stat6-deficient mice have been shown to prolif- (IRES) from encephalomyocarditis virus (EMCV) and an EGFP se-
erate poorly in response to IL-4 (Kaplan et al., 1996; quence from pEGFP-1 (Clontech Laboratories). To generate pMX-
Shimoda et al., 1996; Takeda et al., 1996). Moreover, Stat6:ER-IRES-EGFP (pMX-Stat6:ER), an EcoRI±NotI fragment of
pBabe-puro-Stat6:ER-IRES-EGFP (Dr. Y. Kamogawa, DNAX) waslymphocytes from Stat6-deficient mice have reduced
introduced into the pMXI-EGFP vector. To generate pMX-ER-IRES-IL-4-mediated cdk2 activity and downregulation of p27Kip1
EGFP containing the HBD of the mouse estrogen receptor a (aminoexpression, leading to defective cell cycle progression
acids [aa] 281±599 with an amino acid substitution of Gly to Arg at
(Kaplan et al., 1998). It is still possible that Stat6 may position 525) (ER), an EcoRI±SalI fragment from pBabe-puro-hbER*
mediate its effects on proliferation indirectly as hypothe- (Dr. M. McMahon, DNAX) (Woods et al., 1997) was inserted into
sized by Keegan and Paul (Ryan et al., 1996; Wang et pMXI-EGFP. pMX-DDBD Stat6:ER-IRES-EGFP was prepared by re-
moving a 363 bp Eco47III±StuI fragment corresponding to aa 370±al., 1996; Zamorano and Keegan, 1998). In support of
Immunity
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491 of Stat6 from pMX-Stat6:ER. pMX-mut DBD Stat6:ER-IRES- levels were quantified by autoradiography using fluorescent scanner
Storm (Molecular Dynamics).EGFP was constructed by PCR-directed mutagenesis of EAA for
VVI at positions aa 411±413 of Stat6 (Mikita et al., 1996). pMX-DTAD
Stat6:ER-IRES-EGFP was prepared by removing a 525 bp fragment Acknowledgments
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